Peri-operative Reparixin therapy resulted in 50% 5-year insulin independence rate: The University of Chicago experience
Clin Transplant
.
2023 May;37(5):e14981.
doi: 10.1111/ctr.14981.
Epub 2023 Apr 4.
Authors
Mateusz Ogledzinski
1
,
Piotr J Bachul
1
,
Kourosh Rezania
2
,
Seenu M Hariprasad
3
,
Sarah Gondek
1
,
William Lin
1
,
Braden Juengel
1
,
Kamila Milejczyk
1
,
Lindsay Basto
1
,
Ling-Jia Wang
1
,
Laurencia Perea
1
,
Martin Tibudan
1
,
Rolf N Barth
1
,
John J Fung
1
,
Piotr Witkowski
1
Affiliations
1
Transplantation Institute, Department of Surgery, University of Chicago, Chicago, Illinois, USA.
2
Department of Neurology, University of Chicago, Chicago, Illinois, USA.
3
Department of Ophthalmology and Visual Science, University of Chicago, Chicago, Illinois, USA.
PMID:
37013956
DOI:
10.1111/ctr.14981
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Insulin* / therapeutic use
Sulfonamides*
Substances
Insulin
reparixin
Sulfonamides
Grants and funding
P30 DK020595/DK/NIDDK NIH HHS/United States